Recent advances on the δ opioid receptor: From trafficking to function

British Journal of Pharmacology

Volumn 172, Issue 2, 2015, Pages 403-419

  Gendron, Louis ^a   Mittal, Nitish ^b   Beaudry, Hélène ^a   Walwyn, Wendy ^b  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

pain; primary afferent neurons; receptor trafficking; arrestin; opioid receptor; opioid receptor

Indexed keywords

4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; AZD 2327; BETA ARRESTIN 1; CELL SURFACE RECEPTOR; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; DIMER; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; G PROTEIN COUPLED RECEPTOR; LIM KINASE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; RHO ASSOCIATED COILED COIL CONTAINING PROTEIN KINASE; RHO KINASE; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ANALGESIA; ANXIETY; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; CHRONIC PAIN; COCAINE DEPENDENCE; CONVULSION; DEPRESSION; DIMERIZATION; DRUG ABUSE; DRUG SEEKING BEHAVIOR; EMBRYO DEVELOPMENT; HUMAN; HYPERALGESIA; HYPOXIA; IMMUNOMODULATION; INFLAMMATORY PAIN; INTERNALIZATION; LEARNING; MAJOR DEPRESSION; MEMORY; MORPHINE ADDICTION; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; OPIATE ADDICTION; PAIN; PROTEIN INTERACTION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; SPINAL GANGLION; STRESS; TOUCH; UNSPECIFIED SIDE EFFECT; ANIMAL; METABOLISM; PROTEIN TRANSPORT; UPREGULATION;

ANIMALS; HUMANS; PROTEIN TRANSPORT; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU; UP-REGULATION;

EID: 84920159838     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12706     Document Type: Review

References (249)

1. Abrahamsen B, Zhao J, Asante CO, Cendan CM, Marsh S, Martinez-Barbera JP, et al. (2008). The cell and molecular basis of mechanical, cold, and inflammatory pain. Science 321: 702-705.
2. Achour L, Labbe-Jullie C, Scott MG, Marullo S, (2008). An escort for GPCRs: implications for regulation of receptor density at the cell surface. Trends Pharmacol Sci 29: 528-535.
3. Al-Hasani R, Bruchas MR, (2011). Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology 115: 1363-1381.
4. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Catterall WA, Spedding M, Peters JA, Harmar AJ, and CGTP Collaborators (2013). The Concise Guide to PHARMACOLOGY 2013/14: G-Protein Coupled Receptors. Br J Pharmacol 170: 1459-1581.
5. Arttamangkul S, Torrecilla M, Kobayashi K, Okano H, Williams JT, (2006). Separation of mu-opioid receptor desensitization and internalization: endogenous receptors in primary neuronal cultures. J Neurosci 26: 4118-4125.
6. Arvidsson U, Dado RJ, Riedl M, Lee JH, Law PY, Loh HH, et al. (1995). delta-Opioid receptor immunoreactivity: distribution in brainstem and spinal cord, and relationship to biogenic amines and enkephalin. J Neurosci 15: 1215-1235.
7. Audet N, Charfi I, Mnie-Filali O, Amraei M, Chabot-Dore AJ, Millecamps M, et al. (2012). Differential association of receptor-Gβγ complexes with β-arrestin2 determines recycling bias and potential for tolerance of δ opioid receptor agonists. J Neurosci 32: 4827-4840.
8. Bao L, Jin SX, Zhang C, Wang LH, Xu ZZ, Zhang FX, et al. (2003). Activation of delta opioid receptors induces receptor insertion and neuropeptide secretion. Neuron 37: 121-133.
9. Bardoni R, Tawfik VL, Wang D, François A, Solorzano C, Shuster SA, et al. (2014). Delta opioid receptors presynaptically regulate cutaneous mechanosensory neuron input to the spinal cord dorsal horn. Neuron 81: 1312-1327.
10. Barg J, Levy R, Simantov R, (1984). Up-regulation of opiate receptors by opiate antagonists in neuroblastoma-glioma cell culture: the possibility of interaction with guanosine triphosphate-binding proteins. Neurosci Lett 50: 133-137.
11. Beaudry H, Proteau-Gagne A, Li S, Dory Y, Chavkin C, Gendron L, (2009). Differential noxious and motor tolerance of chronic delta opioid receptor agonists in rodents. Neuroscience 161: 381-391.
12. Benard A, Boue J, Chapey E, Jaume M, Gomes B, Dietrich G, (2008). Delta opioid receptors mediate chemotaxis in bone marrow-derived dendritic cells. J Neuroimmunol 197: 21-28.
13. Bertran-Gonzalez J, Laurent V, Chieng BC, Christie MJ, Balleine BW, (2013). Learning-related translocation of delta-opioid receptors on ventral striatal cholinergic interneurons mediates choice between goal-directed actions. J Neurosci 33: 16060-16071.
14. Billa SK, Xia Y, Moron JA, (2010). Disruption of morphine-conditioned place preference by a delta2-opioid receptor antagonist: study of mu-opioid and delta-opioid receptor expression at the synapse. Eur J Neurosci 32: 625-631.
15. Bodnar RJ, (2013). Endogenous opiates and behavior: 2012. Peptides 50C: 55-95.
16. Bosse KE, Jutkiewicz EM, Schultz-Kuszak KN, Mabrouk OS, Kennedy RT, Gnegy ME, et al. (2014). Synergistic activity between the delta-opioid agonist SNC80 and amphetamine occurs via a glutamatergic NMDA-receptor dependent mechanism. Neuropharmacology 77: 19-27.
17. Brady LS, Herkenham M, Rothman RB, Partilla JS, Konig M, Zimmer AM, et al. (1999). Region-specific up-regulation of opioid receptor binding in enkephalin knockout mice. Brain Res Mol Brain Res 68: 193-197.
18. Broom DC, Jutkiewicz EM, Folk JE, Traynor JR, Rice KC, Woods JH, (2002a). Convulsant activity of a non-peptidic delta-opioid receptor agonist is not required for its antidepressant-like effects in Sprague-Dawley rats. Psychopharmacology (Berl) 164: 42-48.
19. Broom DC, Nitsche JF, Pintar JE, Rice KC, Woods JH, Traynor JR, (2002b). Comparison of receptor mechanisms and efficacy requirements for delta-agonist-induced convulsive activity and antinociception in mice. J Pharmacol Exp Ther 303: 723-729.
20. Cahill CM, McClellan KA, Morinville A, Hoffert C, Hubatsch D, O'Donnell D, et al. (2001a). Immunohistochemical distribution of delta opioid receptors in the rat central nervous system: evidence for somatodendritic labeling and antigen-specific cellular compartmentalization. J Comp Neurol 440: 65-84.
21. Cahill CM, Morinville A, Lee MC, Vincent JP, Collier B, Beaudet A, (2001b). Prolonged morphine treatment targets delta opioid receptors to neuronal plasma membranes and enhances delta-mediated antinociception. J Neurosci 21: 7598-7607.
22. Cahill CM, Morinville A, Hoffert C, O'Donnell D, Beaudet A, (2003). Up-regulation and trafficking of delta opioid receptor in a model of chronic inflammation: implications for pain control. Pain 101: 199-208.
23. Cahill CM, Holdridge SV, Morinville A, (2007). Trafficking of delta-opioid receptors and other G-protein-coupled receptors: implications for pain and analgesia. Trends Pharmacol Sci 28: 23-31.
24. Cavanaugh DJ, Lee H, Lo L, Shields SD, Zylka MJ, Basbaum AI, et al. (2009). Distinct subsets of unmyelinated primary sensory fibers mediate behavioral responses to noxious thermal and mechanical stimuli. Proc Natl Acad Sci U S A 106: 9075-9080.
25. Cen B, Xiong Y, Ma L, Pei G, (2001a). Direct and differential interaction of beta-arrestins with the intracellular domains of different opioid receptors. Mol Pharmacol 59: 758-764.
26. Cen B, Yu Q, Guo J, Wu Y, Ling K, Cheng Z, et al. (2001b). Direct binding of beta-arrestins to two distinct intracellular domains of the delta opioid receptor. J Neurochem 76: 1887-1894.
27. Charbogne P, Kieffer BL, Befort K, (2014). 15 years of genetic approaches in vivo for addiction research: opioid receptor and peptide gene knockout in mouse models of drug abuse. Neuropharmacology 76 (Pt B): 204-217.
28. Charness ME, Querimit LA, Diamond I, (1986). Ethanol increases the expression of functional delta-opioid receptors in neuroblastoma x glioma NG108-15 hybrid cells. J Biol Chem 261: 3164-3169.
29. Chefer VI, Shippenberg TS, (2009). Augmentation of morphine-induced sensitization but reduction in morphine tolerance and reward in delta-opioid receptor knockout mice. Neuropsychopharmacology 34: 887-898.
30. Chen JJ, Dymshitz J, Vasko MR, (1997). Regulation of opioid receptors in rat sensory neurons in culture. Mol Pharmacol 51: 666-673.
31. Chen SR, Pan HL, (2006). Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia. J Neurophysiol 95: 3086-3096.
32. Cheng B, Liu HW, Fu XB, Sheng ZY, Li JF, (2008). Coexistence and upregulation of three types of opioid receptors, mu, delta and kappa, in human hypertrophic scars. Br J Dermatol 158: 713-720.
33. Cheng PY, Svingos AL, Wang H, Clarke CL, Jenab S, Beczkowska IW, et al. (1995). Ultrastructural immunolabeling shows prominent presynaptic vesicular localization of delta-opioid receptor within both enkephalin- and nonenkephalin-containing axon terminals in the superficial layers of the rat cervical spinal cord. J Neurosci 15: 5976-5988.
34. Cheng PY, Liu-Chen LY, Pickel VM, (1997). Dual ultrastructural immunocytochemical labeling of mu and delta opioid receptors in the superficial layers of the rat cervical spinal cord. Brain Res 778: 367-380.
35. Chieng B, Christie MJ, (2009). Chronic morphine treatment induces functional delta-opioid receptors in amygdala neurons that project to periaqueductal grey. Neuropharmacology 57: 430-437.
36. Chu P, Murray S, Lissin D, von Zastrow M, (1997). Delta and kappa opioid receptors are differentially regulated by dynamin-dependent endocytosis when activated by the same alkaloid agonist. J Biol Chem 272: 27124-27130.
37. Comer SD, Hoenicke EM, Sable AI, McNutt RW, Chang KJ, De Costa BR, et al. (1993). Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice. J Pharmacol Exp Ther 267: 888-895.
38. Cox BM, Christie MJ, Devi L, Toll L, Traynor JR, (2015). Challenges for opioid receptor nomenclature: IUPHAR Review 9. Br J Pharmacol 172: 317-323.
39. Crain BJ, Chang KJ, McNamara JO, (1986). Quantitative autoradiographic analysis of mu and delta opioid binding sites in the rat hippocampal formation. J Comp Neurol 246: 170-180.
40. Crist RC, Ambrose-Lanci LM, Vaswani M, Clarke TK, Zeng A, Yuan C, et al. (2013). Case-control association analysis of polymorphisms in the delta-opioid receptor, OPRD1, with cocaine and opioid addicted populations. Drug Alcohol Depend 127: 122-128.
41. Dang VC, Christie MJ, (2012). Mechanisms of rapid opioid receptor desensitization, resensitization and tolerance in brain neurons. Br J Pharmacol 165: 1704-1716.
42. Dang VC, Chieng B, Azriel Y, Christie MJ, (2011). Cellular morphine tolerance produced by betaarrestin-2-dependent impairment of mu-opioid receptor resensitization. J Neurosci 31: 7122-7130.
43. Danks JA, Tortella FC, Long JB, Bykov V, Jacobson AE, Rice KC, et al. (1988). Chronic administration of morphine and naltrexone up-regulate[3H][D-Ala2,D-leu5]enkephalin binding sites by different mechanisms. Neuropharmacology 27: 965-974.
44. Decaillot FM, Rozenfeld R, Gupta A, Devi LA, (2008). Cell surface targeting of mu-delta opioid receptor heterodimers by RTP4. Proc Natl Acad Sci U S A 105: 16045-16050.
45. DeFea KA, (2007). Stop that cell! Beta-arrestin-dependent chemotaxis: a tale of localized actin assembly and receptor desensitization. Annu Rev Physiol 69: 535-560.
46. Dickenson AH, (1997). Plasticity: implications for opioid and other pharmacological interventions in specific pain states. Behav Brain Sci 20: 392-403, discussion 435-513.
47. Dikshtein Y, Barnea R, Kronfeld N, Lax E, Roth-Deri I, Friedman A, et al. (2013). Beta-endorphin via the delta opioid receptor is a major factor in the incubation of cocaine craving. Neuropsychopharmacology 38: 2508-2514.
48. Doll C, Konietzko J, Poll F, Koch T, Hollt V, Schulz S, (2011). Agonist-selective patterns of micro-opioid receptor phosphorylation revealed by phosphosite-specific antibodies. Br J Pharmacol 164: 298-307.
49. Dong C, Filipeanu CM, Duvernay MT, Wu G, (2007). Regulation of G protein-coupled receptor export trafficking. Biochim Biophys Acta 1768: 853-870.
50. Dubois D, Gendron L, (2010). Delta opioid receptor-mediated analgesia is not altered in preprotachykinin A knockout mice. Eur J Neurosci 32: 1921-1929.
51. Egea G, Lazaro-Dieguez F, Vilella M, (2006). Actin dynamics at the Golgi complex in mammalian cells. Curr Opin Cell Biol 18: 168-178.
52. Elde R, Arvidsson U, Riedl M, Vulchanova L, Lee JH, Dado R, et al. (1995). Distribution of neuropeptide receptors. New views of peptidergic neurotransmission made possible by antibodies to opioid receptors. Ann N Y Acad Sci 757: 390-404.
53. Erbs E, Faget L, Scherrer G, Kessler P, Hentsch D, Vonesch JL, et al. (2012). Distribution of delta opioid receptor-expressing neurons in the mouse hippocampus. Neuroscience 221: 203-213.
54. Erbs E, Faget L, Scherrer G, Matifas A, Filliol D, Vonesch JL, et al. (2014). A mu-delta opioid receptor brain atlas reveals neuronal co-occurrence in subcortical networks. Brain Struct Funct [E-pub ahead of print] doi: 10.1007/500429-014-0717-9.
55. Fischbach PS, Barrett TD, Reed NJ, Lucchesi BR, (2003). SNC-80-induced preconditioning: selective activation of the mitochondrial adenosine triphosphate-gated potassium channel. J Cardiovasc Pharmacol 41: 744-750.
56. Fourla DD, Papakonstantinou MP, Vrana SM, Georgoussi Z, (2012). Selective interactions of spinophilin with the C-terminal domains of the delta- and mu-opioid receptors and G proteins differentially modulate opioid receptor signaling. Cell Signal 24: 2315-2328.
57. Fristad I, Berggreen E, Haug SR, (2006). Delta (delta) opioid receptors in small and medium-sized trigeminal neurons supporting the dental pulp of rats. Arch Oral Biol 51: 273-281.
58. Gallego MJ, Porayette P, Kaltcheva MM, Meethal SV, Atwood CS, (2009). Opioid and progesterone signaling is obligatory for early human embryogenesis. Stem Cells Dev 18: 737-740.
59. Gao CJ, Niu L, Ren PC, Wang W, Zhu C, Li YQ, et al. (2012). Hypoxic preconditioning attenuates global cerebral ischemic injury following asphyxial cardiac arrest through regulation of delta opioid receptor system. Neuroscience 202: 352-362.
60. Gaudriault G, Nouel D, Dal Farra C, Beaudet A, Vincent JP, (1997). Receptor-induced internalization of selective peptidic mu and delta opioid ligands. J Biol Chem 272: 2880-2888.
61. Gaveriaux-Ruff C, Kieffer BL, (2011). Delta opioid receptor analgesia: recent contributions from pharmacology and molecular approaches. Behav Pharmacol 22: 405-414.
62. Gaveriaux-Ruff C, Nozaki C, Nadal X, Hever XC, Weibel R, Matifas A, et al. (2011). Genetic ablation of delta opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes opioid analgesia. Pain 152: 1238-1248.
63. Ge X, Loh HH, Law PY, (2009). mu-Opioid receptor cell surface expression is regulated by its direct interaction with Ribophorin I. Mol Pharmacol 75: 1307-1316.
64. Gendron L, Lucido AL, Mennicken F, O'Donnell D, Vincent JP, Stroh T, et al. (2006). Morphine and pain-related stimuli enhance cell surface availability of somatic delta-opioid receptors in rat dorsal root ganglia. J Neurosci 26: 953-962.
65. Gendron L, Esdaile MJ, Mennicken F, Pan H, O'Donnell D, Vincent JP, et al. (2007a). Morphine priming in rats with chronic inflammation reveals a dichotomy between antihyperalgesic and antinociceptive properties of deltorphin. Neuroscience 144: 263-274.
66. Gendron L, Pintar JE, Chavkin C, (2007b). Essential role of mu opioid receptor in the regulation of delta opioid receptor-mediated antihyperalgesia. Neuroscience 150: 807-817.
67. Georganta EM, Agalou A, Georgoussi Z, (2010). Multi-component signaling complexes of the delta-opioid receptor with STAT5B and G proteins. Neuropharmacology 59: 139-148.
68. George SR, Fan T, Xie Z, Tse R, Tam V, Varghese G, et al. (2000). Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. J Biol Chem 275: 26128-26135.
69. Georgoussi Z, Georganta EM, Milligan G, (2012). The other side of opioid receptor signalling: regulation by protein-protein interaction. Curr Drug Targets 13: 80-102.
70. Golebiewska U, Johnston JM, Devi L, Filizola M, Scarlata S, (2011). Differential response to morphine of the oligomeric state of mu-opioid in the presence of delta-opioid receptors. Biochemistry 50: 2829-2837.
71. Gomes I, Jordan BA, Gupta A, Trapaidze N, Nagy V, Devi LA, (2000). Heterodimerization of mu and delta opioid receptors: a role in opiate synergy. J Neurosci 20: RC110.
72. Gomes I, Gupta A, Filipovska J, Szeto HH, Pintar JE, Devi LA, (2004). A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia. Proc Natl Acad Sci U S A 101: 5135-5139.
73. Gomes I, Fujita W, Gupta A, Saldanha AS, Negri A, Pinello CE, et al. (2013). Identification of a mu-delta opioid receptor heteromer-biased agonist with antinociceptive activity. Proc Natl Acad Sci U S A 110: 12072-12077.
74. Guan JS, Xu ZZ, Gao H, He SQ, Ma GQ, Sun T, et al. (2005). Interaction with vesicle luminal protachykinin regulates surface expression of delta-opioid receptors and opioid analgesia. Cell 122: 619-631.
75. Guo XH, Fairbanks CA, Stone LS, Loh HH, (2003). DPDPE-UK14,304 synergy is retained in mu opioid receptor knockout mice. Pain 104: 209-217.
76. Gupta A, Mulder J, Gomes I, Rozenfeld R, Bushlin I, Ong E, et al. (2010). Increased abundance of opioid receptor heteromers after chronic morphine administration. Sci Signal 3: ra54.
77. Hack SP, Bagley EE, Chieng BC, Christie MJ, (2005). Induction of delta-opioid receptor function in the midbrain after chronic morphine treatment. J Neurosci 25: 3192-3198.
78. Hagenacker T, Hillebrand I, Wissmann A, Busselberg D, Schafers M, (2010). Anti-allodynic effect of the flavonoid myricetin in a rat model of neuropathic pain: involvement of p38 and protein kinase C mediated modulation of Ca(2) + channels. Eur J Pain 14: 992-998.
79. Hamel E, Beaudet A, (1984). Electron microscopic autoradiographic localization of opioid receptors in rat neostriatum. Nature 312: 155-157.
80. Hasbi A, Allouche S, Sichel F, Stanasila L, Massotte D, Landemore G, et al. (2000). Internalization and recycling of delta-opioid receptor are dependent on a phosphorylation-dephosphorylation mechanism. J Pharmacol Exp Ther 293: 237-247.
81. Hasbi A, Nguyen T, Fan T, Cheng R, Rashid A, Alijaniaram M, et al. (2007). Trafficking of preassembled opioid mu-delta heterooligomer-Gz signaling complexes to the plasma membrane: coregulation by agonists. Biochemistry 46: 12997-13009.
82. Hauser KF, Houdi AA, Turbek CS, Elde RP, Maxson W 3rd, (2000). Opioids intrinsically inhibit the genesis of mouse cerebellar granule neuron precursors in vitro: differential impact of mu and delta receptor activation on proliferation and neurite elongation. Eur J Neurosci 12: 1281-1293.
83. He L, Lee NM, (1998). Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord. J Pharmacol Exp Ther 285: 1181-1186.
84. He SQ, Zhang ZN, Guan JS, Liu HR, Zhao B, Wang HB, et al. (2011). Facilitation of mu-opioid receptor activity by preventing delta-opioid receptor-mediated codegradation. Neuron 69: 120-131.
85. He X, Yang Y, Zhi F, Moore ML, Kang X, Chao D, et al. (2013). delta-Opioid receptor activation modified microRNA expression in the rat kidney under prolonged hypoxia. PLoS ONE 8: e61080.
86. Heimann K, Percival JM, Weinberger R, Gunning P, Stow JL, (1999). Specific isoforms of actin-binding proteins on distinct populations of Golgi-derived vesicles. J Biol Chem 274: 10743-10750.
87. Henry AG, White IJ, Marsh M, von Zastrow M, Hislop JN, (2010). The role of ubiquitination in lysosomal trafficking of delta-opioid receptors. Traffic 12: 170-184.
88. Hille CJ, Fox SH, Maneuf YP, Crossman AR, Brotchie JM, (2001). Antiparkinsonian action of a delta opioid agonist in rodent and primate models of Parkinson's disease. Exp Neurol 172: 189-198.
89. Holdridge SV, Cahill CM, (2007). Spinal administration of a delta opioid receptor agonist attenuates hyperalgesia and allodynia in a rat model of neuropathic pain. Eur J Pain 11: 685-693.
90. Hosohata Y, Vanderah TW, Burkey TH, Ossipov MH, Kovelowski CJ, Sora I, et al. (2000). delta-Opioid receptor agonists produce antinociception and [35S]GTPgammaS binding in mu receptor knockout mice. Eur J Pharmacol 388: 241-248.
91. Hudzik TJ, Maciag C, Smith MA, Caccese R, Pietras MR, Bui KH, et al. (2011). Preclinical pharmacology of AZD2327: a highly selective agonist of the delta-opioid receptor. J Pharmacol Exp Ther 338: 195-204.
92. Hurley RW, Hammond DL, (2000). The analgesic effects of supraspinal mu and delta opioid receptor agonists are potentiated during persistent inflammation. J Neurosci 20: 1249-1259.
93. Husain S, Abdul Y, Potter DE, (2012). Non-analgesic effects of opioids: neuroprotection in the retina. Curr Pharm Des 18: 6101-6108.
94. Hylden JL, Thomas DA, Iadarola MJ, Nahin RL, Dubner R, (1991). Spinal opioid analgesic effects are enhanced in a model of unilateral inflammation/hyperalgesia: possible involvement of noradrenergic mechanisms. Eur J Pharmacol 194: 135-143.
95. Iaizzo PA, Laske TG, Harlow HJ, McClay CB, Garshelis DL, (2012). Wound healing during hibernation by black bears (Ursus americanus) in the wild: elicitation of reduced scar formation. Integr Zool 7: 48-60.
96. Jenab S, Inturrisi CE, (1997). Activation of protein kinase A prevents the ethanol-induced up-regulation of delta-opioid receptor mRNA in NG108-15 cells. Brain Res Mol Brain Res 47: 44-48.
97. Jordan BA, Devi LA, (1999). G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399: 697-700.
98. Joseph EK, Levine JD, (2010). Mu and delta opioid receptors on nociceptors attenuate mechanical hyperalgesia in rat. Neuroscience 171: 344-350.
99. Jutkiewicz EM, Rice KC, Woods JH, Winsauer PJ, (2003). Effects of the delta-opioid receptor agonist SNC80 on learning relative to its antidepressant-like effects in rats. Behav Pharmacol 14: 509-516.
100. Jutkiewicz EM, Kaminsky ST, Rice KC, Traynor JR, Woods JH, (2005a). Differential behavioral tolerance to the delta-opioid agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl ]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in Sprague-Dawley rats. J Pharmacol Exp Ther 315: 414-422.
101. Jutkiewicz EM, Rice KC, Traynor JR, Woods JH, (2005b). Separation of the convulsions and antidepressant-like effects produced by the delta-opioid agonist SNC80 in rats. Psychopharmacology (Berl) 182: 588-596.
102. Jutkiewicz EM, Baladi MG, Folk JE, Rice KC, Woods JH, (2006). The convulsive and electroencephalographic changes produced by nonpeptidic delta-opioid agonists in rats: comparison with pentylenetetrazol. J Pharmacol Exp Ther 317: 1337-1348.
103. Kabli N, Cahill CM, (2007). Anti-allodynic effects of peripheral delta opioid receptors in neuropathic pain. Pain 127: 84-93.
104. Kabli N, Martin N, Fan T, Nguyen T, Hasbi A, Balboni G, et al. (2010). Agonists at the delta-opioid receptor modify the binding of micro-receptor agonists to the micro-delta receptor hetero-oligomer. Br J Pharmacol 161: 1122-1136.
105. Kabli N, Nguyen T, Balboni G, O'Dowd BF, George SR, (2013). Antidepressant-like and anxiolytic-like effects following activation of the μ-δ opioid receptor heteromer in the nucleus accumbens. Mol Psychiatry [E-pub ahead of print] doi: 10.1038/mp.2013-115.
106. Keith DE, Murray SR, Zaki PA, Chu PC, Lissin DV, Kang L, et al. (1996). Morphine activates opioid receptors without causing their rapid internalization. J Biol Chem 271: 19021-19024.
107. Kest B, Lee CE, McLemore GL, Inturrisi CE, (1996). An antisense oligodeoxynucleotide to the delta opioid receptor (DOR-1) inhibits morphine tolerance and acute dependence in mice. Brain Res Bull 39: 185-188.
108. Khavandgar S, Homayoun H, Dehpour AR, (2002). The role of nitric oxide in the proconvulsant effect of delta-opioid agonist SNC80 in mice. Neurosci Lett 329: 237-239.
109. Ko JL, Arvidsson U, Williams FG, Law PY, Elde R, Loh HH, (1999). Visualization of time-dependent redistribution of delta-opioid receptors in neuronal cells during prolonged agonist exposure. Brain Res Mol Brain Res 69: 171-185.
110. Kondo I, Marvizon JC, Song B, Salgado F, Codeluppi S, Hua XY, et al. (2005). Inhibition by spinal mu- and delta-opioid agonists of afferent-evoked substance P release. J Neurosci 25: 3651-3660.
111. Kotlinska JH, Gibula-Bruzda E, Witkowska E, Izdebski J, (2010). Involvement of delta and mu opioid receptors in the acute and sensitized locomotor action of cocaine in mice. Peptides 48: 89-95.
112. Kouchek M, Takasusuki T, Terashima T, Yaksh TL, Xu Q, (2013). Effects of intrathecal SNC80, a delta receptor ligand, on nociceptive threshold and dorsal horn substance p release. J Pharmacol Exp Ther 347: 258-264.
113. Kovoor A, Celver J, Abdryashitov RI, Chavkin C, Gurevich VV, (1999). Targeted construction of phosphorylation-independent beta-arrestin mutants with constitutive activity in cells. J Biol Chem 274: 6831-6834.
114. Kramer HK, Andria ML, Kushner SA, Esposito DH, Hiller JM, Simon EJ, (2000). Mutation of tyrosine 318 (Y318F) in the delta-opioid receptor attenuates tyrosine phosphorylation, agonist-dependent receptor internalization, and mitogen-activated protein kinase activation. Brain Res Mol Brain Res 79: 55-66.
115. Lamberts JT, Smith CE, Li MH, Ingram SL, Neubig RR, Traynor JR, (2013). Differential control of opioid antinociception to thermal stimuli in a knock-in mouse expressing regulator of G-protein signaling-insensitive Galphao protein. J Neurosci 33: 4369-4377.
116. Laurent V, Leung B, Maidment N, Balleine BW, (2012). mu- and delta-opioid-related processes in the accumbens core and shell differentially mediate the influence of reward-guided and stimulus-guided decisions on choice. J Neurosci 32: 1875-1883.
117. Law PY, Wong YH, Loh HH, (1999). Mutational analysis of the structure and function of opioid receptors. Biopolymers 51: 440-455.
118. Law PY, Kouhen OM, Solberg J, Wang W, Erickson LJ, Loh HH, (2000). Deltorphin II-induced rapid desensitization of delta-opioid receptor requires both phosphorylation and internalization of the receptor. J Biol Chem 275: 32057-32065.
119. Law PY, Erickson-Herbrandson LJ, Zha QQ, Solberg J, Chu J, Sarre A, et al. (2005). Heterodimerization of mu- and delta-opioid receptors occurs at the cell surface only and requires receptor-G protein interactions. J Biol Chem 280: 11152-11164.
120. Le Merrer J, Becker JA, Befort K, Kieffer BL, (2009). Reward processing by the opioid system in the brain. Physiol Rev 89: 1379-1412.
121. Le Merrer J, Plaza-Zabala A, Del Boca C, Matifas A, Maldonado R, Kieffer BL, (2011). Deletion of the delta opioid receptor gene impairs place conditioning but preserves morphine reinforcement. Biol Psychiatry 69: 700-703.
122. Le Merrer J, Faget L, Matifas A, Kieffer BL, (2012). Cues predicting drug or food reward restore morphine-induced place conditioning in mice lacking delta opioid receptors. Psychopharmacology (Berl) 223: 99-106.
123. Le Merrer J, Rezai X, Scherrer G, Becker JA, Kieffer BL, (2013). Impaired hippocampus-dependent and facilitated striatum-dependent behaviors in mice lacking the delta opioid receptor. Neuropsychopharmacology 38: 1050-1059.
124. Leontiadis LJ, Papakonstantinou MP, Georgoussi Z, (2009). Regulator of G protein signaling 4 confers selectivity to specific G proteins to modulate mu- and delta-opioid receptor signaling. Cell Signal 21: 1218-1228.
125. Leskela TT, Markkanen PM, Pietila EM, Tuusa JT, Petaja-Repo UE, (2007). Opioid receptor pharmacological chaperones act by binding and stabilizing newly synthesized receptors in the endoplasmic reticulum. J Biol Chem 282: 23171-23183.
126. Liu X, Kai M, Jin L, Wang R, (2009). Molecular modeling studies to predict the possible binding modes of endomorphin analogs in mu opioid receptor. Bioorg Med Chem Lett 19: 5387-5391.
127. Loh HH, Liu HC, Cavalli A, Yang W, Chen YF, Wei LN, (1998). mu Opioid receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality. Brain Res Mol Brain Res 54: 321-326.
128. Lowe JD, Celver JP, Gurevich VV, Chavkin C, (2002). mu-Opioid receptors desensitize less rapidly than delta-opioid receptors due to less efficient activation of arrestin. J Biol Chem 277: 15729-15735.
129. Lowe M, (2011). Structural organization of the Golgi apparatus. Curr Opin Cell Biol 23: 85-93.
130. Lucido AL, Morinville A, Gendron L, Stroh T, Beaudet A, (2005). Prolonged morphine treatment selectively increases membrane recruitment of delta-opioid receptors in mouse basal ganglia. J Mol Neurosci 25: 207-214.
131. Lutz PE, Kieffer BL, (2013). The multiple facets of opioid receptor function: implications for addiction. Curr Opin Neurobiol 23: 473-479.
132. Ma J, Zhang Y, Kalyuzhny AE, Pan ZZ, (2006). Emergence of functional delta-opioid receptors induced by long-term treatment with morphine. Mol Pharmacol 69: 1137-1145.
133. Ma MC, Qian H, Ghassemi F, Zhao P, Xia Y, (2005). Oxygen-sensitive {delta}-opioid receptor-regulated survival and death signals: novel insights into neuronal preconditioning and protection. J Biol Chem 280: 16208-16218.
134. Mabrouk OS, Marti M, Salvadori S, Morari M, (2009). The novel delta opioid receptor agonist UFP-512 dually modulates motor activity in hemiparkinsonian rats via control of the nigro-thalamic pathway. Neuroscience 164: 360-369.
135. Madziva MT, Edwardson JM, (2001). Trafficking of green fluorescent protein-tagged muscarinic M4 receptors in NG108-15 cells. Eur J Pharmacol 428: 9-18.
136. Malmberg AB, Yaksh TL, (1992). Isobolographic and dose-response analyses of the interaction between intrathecal mu and delta agonists: effects of naltrindole and its benzofuran analog (NTB). J Pharmacol Exp Ther 263: 264-275.
137. Mansour A, Fox CA, Burke S, Meng F, Thompson RC, Akil H, et al. (1994a). Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J Comp Neurol 350: 412-438.
138. Mansour A, Fox CA, Thompson RC, Akil H, Watson SJ, (1994b). mu-Opioid receptor mRNA expression in the rat CNS: comparison to mu-receptor binding. Brain Res 643: 245-265.
139. Mansour A, Fox CA, Akil H, Watson SJ, (1995). Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci 18: 22-29.
140. Margolis EB, Fields HL, Hjelmstad GO, Mitchell JM, (2008). Delta-opioid receptor expression in the ventral tegmental area protects against elevated alcohol consumption. J Neurosci 28: 12672-12681.
141. Maslov LN, Naryzhnaia NV, Tsibulnikov SY, Kolar F, Zhang Y, Wang H, et al. (2013). Role of endogenous opioid peptides in the infarct size-limiting effect of adaptation to chronic continuous hypoxia. Life Sci 93: 373-379.
142. Matthes HW, Smadja C, Valverde O, Vonesch JL, Foutz AS, Boudinot E, et al. (1998). Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the mu-receptor. J Neurosci 18: 7285-7295.
143. McDonald NA, Henstridge CM, Connolly CN, Irving AJ, (2007). Generation and functional characterization of fluorescent, N-terminally tagged CB1 receptor chimeras for live-cell imaging. Mol Cell Neurosci 35: 237-248.
144. McLean AJ, Milligan G, (2000). Ligand regulation of green fluorescent protein-tagged forms of the human beta(1)- and beta(2)-adrenoceptors; comparisons with the unmodified receptors. Br J Pharmacol 130: 1825-1832.
145. Mennicken F, Zhang J, Hoffert C, Ahmad S, Beaudet A, O'Donnell D, (2003). Phylogenetic changes in the expression of delta opioid receptors in spinal cord and dorsal root ganglia. J Comp Neurol 465: 349-360.
146. Metcalf MD, Yekkirala AS, Powers MD, Kitto KF, Fairbanks CA, Wilcox GL, et al. (2012). The delta opioid receptor agonist SNC80 selectively activates heteromeric mu-delta opioid receptors. ACS Chem Neurosci 3: 505-509.
147. Miaskowski C, Taiwo YO, Levine JD, (1990). Kappa- and delta-opioid agonists synergize to produce potent analgesia. Brain Res 509: 165-168.
148. Miaskowski C, Sutters KA, Taiwo YO, Levine JD, (1991). Comparison of the antinociceptive and motor effects of intrathecal opioid agonists in the rat. Brain Res 553: 105-109.
149. Milan-Lobo L, Whistler JL, (2011). Heteromerization of the mu- and delta-opioid receptors produces ligand-biased antagonism and alters mu-receptor trafficking. J Pharmacol Exp Ther 337: 868-875.
150. Mitchell JM, Margolis EB, Coker AR, Fields HL, (2012). Alcohol self-administration, anxiety, and cortisol levels predict changes in delta opioid receptor function in the ventral tegmental area. Behav Neurosci 126: 515-522.
151. Mittal N, Roberts K, Pal K, Bentolila L, Fultz E, Minasyan A, et al. (2013). Select G-protein-coupled receptors modulate agonist-induced signaling via a ROCK, LIMK and β-arrestin 1 pathway. Cell Rep 5: 1010-1021.
152. Morgan MM, Ashley MD, Ingram SL, Christie MJ, (2009). Behavioral consequences of delta-opioid receptor activation in the periaqueductal gray of morphine tolerant rats. Neural Plast 2009: 516328.
153. Morinville A, Cahill CM, Esdaile MJ, Aibak H, Collier B, Kieffer BL, et al. (2003). Regulation of delta-opioid receptor trafficking via mu-opioid receptor stimulation: evidence from mu-opioid receptor knock-out mice. J Neurosci 23: 4888-4898.
154. Morinville A, Cahill CM, Aibak H, Rymar VV, Pradhan A, Hoffert C, et al. (2004a). Morphine-induced changes in delta opioid receptor trafficking are linked to somatosensory processing in the rat spinal cord. J Neurosci 24: 5549-5559.
155. Morinville A, Cahill CM, Kieffer B, Collier B, Beaudet A, (2004b). Mu-opioid receptor knockout prevents changes in delta-opioid receptor trafficking induced by chronic inflammatory pain. Pain 109: 266-273.
156. Nagasaka H, Yaksh TL, (1995). Effects of intrathecal mu, delta, and kappa agonists on thermally evoked cardiovascular and nociceptive reflexes in halothane-anesthetized rats. Anesth Analg 80: 437-443.
157. Navratilova E, Eaton MC, Stropova D, Varga EV, Vanderah TW, Roeske WR, et al. (2005). Morphine promotes phosphorylation of the human delta-opioid receptor at serine 363. Eur J Pharmacol 519: 212-214.
158. Negus SS, Butelman ER, Chang KJ, DeCosta B, Winger G, Woods JH, (1994). Behavioral effects of the systemically active delta opioid agonist BW373U86 in rhesus monkeys. J Pharmacol Exp Ther 270: 1025-1034.
159. Nichols ML, Bian D, Ossipov MH, Lai J, Porreca F, (1995). Regulation of morphine antiallodynic efficacy by cholecystokinin in a model of neuropathic pain in rats. J Pharmacol Exp Ther 275: 1339-1345.
160. Nielsen CK, Simms JA, Li R, Mill D, Yi H, Feduccia AA, et al. (2012). δ-opioid receptor function in the dorsal striatum plays a role in high levels of ethanol consumption in rats. J Neurosci 32: 4540-4552.
161. Nieto MM, Guen SL, Kieffer BL, Roques BP, Noble F, (2005). Physiological control of emotion-related behaviors by endogenous enkephalins involves essentially the delta opioid receptors. Neuroscience 135: 305-313.
162. Norcini M, Vivoli E, Galeotti N, Bianchi E, Bartolini A, Ghelardini C, (2009). Supraspinal role of protein kinase C in oxaliplatin-induced neuropathy in rat. Pain 146: 141-147.
163. Normandin A, Luccarini P, Molat JL, Gendron L, Dallel R, (2013). Spinal μ and δ opioids inhibit both thermal and mechanical pain in rats. J Neurosci 33: 11703-11714.
164. Oeltgen PR, Nilekani SP, Nuchols PA, Spurrier WA, Su TP, (1988). Further studies on opioids and hibernation: delta opioid receptor ligand selectively induced hibernation in summer-active ground squirrels. Life Sci 43: 1565-1574.
165. Otis V, Sarret P, Gendron L, (2011). Spinal activation of delta opioid receptors alleviates cancer-related bone pain. Neuroscience 183: 221-229.
166. Overland AC, Kitto KF, Chabot-Dore AJ, Rothwell PE, Fairbanks CA, Stone LS, et al. (2009). Protein kinase C mediates the synergistic interaction between agonists acting at alpha2-adrenergic and delta-opioid receptors in spinal cord. J Neurosci 29: 13264-13273.
167. Pasquini F, Bochet P, Garbay-Jaureguiberry C, Roques BP, Rossier J, Beaudet A, (1992). Electron microscopic localization of photoaffinity-labelled delta opioid receptors in the neostriatum of the rat. J Comp Neurol 326: 229-244.
168. Patwardhan AM, Berg KA, Akopain AN, Jeske NA, Gamper N, Clarke WP, et al. (2005). Bradykinin-induced functional competence and trafficking of the delta-opioid receptor in trigeminal nociceptors. J Neurosci 25: 8825-8832.
169. Pei G, Kieffer BL, Lefkowitz RJ, Freedman NJ, (1995). Agonist-dependent phosphorylation of the mouse delta-opioid receptor: involvement of G protein-coupled receptor kinases but not protein kinase C. Mol Pharmacol 48: 173-177.
170. Pello OM, Martinez-Munoz L, Parrillas V, Serrano A, Rodriguez-Frade JM, Toro MJ, et al. (2008). Ligand stabilization of CXCR4/delta-opioid receptor heterodimers reveals a mechanism for immune response regulation. Eur J Immunol 38: 537-549.
171. Peng PH, Huang HS, Lee YJ, Chen YS, Ma MC, (2009). Novel role for the delta-opioid receptor in hypoxic preconditioning in rat retinas. J Neurochem 108: 741-754.
172. Perl ER, (2007). Ideas about pain, a historical view. Nat Rev Neurosci 8: 71-80.
173. Persson AI, Thorlin T, Bull C, Zarnegar P, Ekman R, Terenius L, et al. (2003). Mu- and delta-opioid receptor antagonists decrease proliferation and increase neurogenesis in cultures of rat adult hippocampal progenitors. Eur J Neurosci 17: 1159-1172.
174. Petaja-Repo UE, Hogue M, Laperriere A, Walker P, Bouvier M, (2000). Export from the endoplasmic reticulum represents the limiting step in the maturation and cell surface expression of the human delta opioid receptor. J Biol Chem 275: 13727-13736.
175. Petaja-Repo UE, Hogue M, Laperriere A, Bhalla S, Walker P, Bouvier M, (2001). Newly synthesized human delta opioid receptors retained in the endoplasmic reticulum are retrotranslocated to the cytosol, deglycosylated, ubiquitinated, and degraded by the proteasome. J Biol Chem 276: 4416-4423.
176. Petaja-Repo UE, Hogue M, Bhalla S, Laperriere A, Morello JP, Bouvier M, (2002). Ligands act as pharmacological chaperones and increase the efficiency of delta opioid receptor maturation. EMBO J 21: 1628-1637.
177. Pettinger L, Gigout S, Linley JE, Gamper N, (2013). Bradykinin controls pool size of sensory neurons expressing functional delta-opioid receptors. J Neurosci 33: 10762-10771.
178. Pippig S, Andexinger S, Daniel K, Puzicha M, Caron MG, Lefkowitz RJ, et al. (1993). Overexpression of beta-arrestin and beta-adrenergic receptor kinase augment desensitization of beta 2-adrenergic receptors. J Biol Chem 268: 3201-3208.
179. Pippig S, Andexinger S, Lohse MJ, (1995). Sequestration and recycling of beta 2-adrenergic receptors permit receptor resensitization. Mol Pharmacol 47: 666-676.
180. Piskorowski RA, Chevaleyre V, (2013). Delta-opioid receptors mediate unique plasticity onto parvalbumin-expressing interneurons in area CA2 of the hippocampus. J Neurosci 33: 14567-14578.
181. Porreca F, Mosberg HI, Hurst R, Hruby VJ, Burks TF, (1984). Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse. J Pharmacol Exp Ther 230: 341-348.
182. Pradhan A, Smith M, McGuire B, Evans C, Walwyn W, (2013). Chronic inflammatory injury results in increased coupling of delta opioid receptors to voltage-gated Ca2+ channels. Mol Pain 9: 8.
183. Pradhan AA, Becker JA, Scherrer G, Tryoen-Toth P, Filliol D, Matifas A, et al. (2009). In vivo delta opioid receptor internalization controls behavioral effects of agonists. PLoS ONE 4: e5425.
184. Pradhan AA, Befort K, Nozaki C, Gaveriaux-Ruff C, Kieffer BL, (2011). The delta opioid receptor: an evolving target for the treatment of brain disorders. Trends Pharmacol Sci 32: 581-590.
185. Pradhan AA, Smith ML, McGuire B, Tarash I, Evans CJ, Charles A, (2014). Characterization of a novel model of chronic migraine. Pain 155: 269-274.
186. Psifogeorgou K, Terzi D, Papachatzaki MM, Varidaki A, Ferguson D, Gold SJ, et al. (2011). A unique role of RGS9-2 in the striatum as a positive or negative regulator of opiate analgesia. J Neurosci 31: 5617-5624.
187. Qiu C, Sora I, Ren K, Uhl G, Dubner R, (2000). Enhanced delta-opioid receptor-mediated antinociception in mu-opioid receptor-deficient mice. Eur J Pharmacol 387: 163-169.
188. Quillinan N, Lau EK, Virk M, von Zastrow M, Williams JT, (2011). Recovery from mu-opioid receptor desensitization after chronic treatment with morphine and methadone. J Neurosci 31: 4434-4443.
189. Randall-Thompson JF, Pescatore KA, Unterwald EM, (2010). A role for delta opioid receptors in the central nucleus of the amygdala in anxiety-like behaviors. Psychopharmacology (Berl) 212: 585-595.
190. Ranganathan P, Chen H, Adelman MK, Schluter SF, (2009). Autoantibodies to the delta-opioid receptor function as opioid agonists and display immunomodulatory activity. J Neuroimmunol 217: 65-73.
191. Rezai X, Faget L, Bednarek E, Schwab Y, Kieffer BL, Massotte D, (2012). Mouse delta opioid receptors are located on presynaptic afferents to hippocampal pyramidal cells. Cell Mol Neurobiol 32: 509-516.
192. Rezai X, Kieffer BL, Roux MJ, Massotte D, (2013). Delta opioid receptors regulate temporoammonic-activated feedforward inhibition to the mouse CA1 hippocampus. PLoS ONE 8: e79081.
193. Riedl MS, Schnell SA, Overland AC, Chabot-Dore AJ, Taylor AM, Ribeiro-da-Silva A, et al. (2009). Coexpression of alpha 2A-adrenergic and delta-opioid receptors in substance P-containing terminals in rat dorsal horn. J Comp Neurol 513: 385-398.
194. van Rijn RM, Whistler JL, Waldhoer M, (2010). Opioid-receptor-heteromer-specific trafficking and pharmacology. Curr Opin Pharmacol 10: 73-79.
195. van Rijn RM, Brissett DI, Whistler JL, (2012). Emergence of functional spinal delta opioid receptors after chronic ethanol exposure. Biol Psychiatry 71: 232-238.
196. van Rijn RM, Defriel JN, Whistler JL, (2013). Pharmacological traits of delta opioid receptors: pitfalls or opportunities? Psychopharmacology (Berl) 228: 1-18.
197. Rivero G, Gabilondo AM, Garcia-Fuster MJ, La Harpe R, Garcia-Sevilla JA, Meana JJ, (2012). Differential regulation of RGS proteins in the prefrontal cortex of short- and long-term human opiate abusers. Neuropharmacology 62: 1044-1051.
198. Roman-Vendrell C, Yu YJ, Yudowski GA, (2012). Fast modulation of mu-opioid receptor (MOR) recycling is mediated by receptor agonists. J Biol Chem 287: 14782-14791.
199. Rothman RB, Bykov V, Long JB, Brady LS, Jacobson AE, Rice KC, et al. (1989). Chronic administration of morphine and naltrexone up-regulate mu-opioid binding sites labeled by [3H][D-Ala2,MePhe4,Gly-ol5]enkephalin: further evidence for two mu-binding sites. Eur J Pharmacol 160: 71-82.
200. Rowan MP, Ruparel NB, Patwardhan AM, Berg KA, Clarke WP, Hargreaves KM, (2009). Peripheral delta opioid receptors require priming for functional competence in vivo. Eur J Pharmacol 602: 283-287.
201. Roy S, Rached M, Gallo-Payet N, (2007). Differential regulation of the human adrenocorticotropin receptor [melanocortin-2 receptor (MC2R)] by human MC2R accessory protein isoforms alpha and beta in isogenic human embryonic kidney 293 cells. Mol Endocrinol 21: 1656-1669.
202. Rozenfeld R, Devi LA, (2007). Receptor heterodimerization leads to a switch in signaling: beta-arrestin2-mediated ERK activation by mu-delta opioid receptor heterodimers. FASEB J 21: 2455-2465.
203. Saitoh A, Kimura Y, Suzuki T, Kawai K, Nagase H, Kamei J, (2004). Potential anxiolytic and antidepressant-like activities of SNC80, a selective delta-opioid agonist, in behavioral models in rodents. J Pharmacol Sci 95: 374-380.
204. Saitoh A, Sugiyama A, Nemoto T, Fujii H, Wada K, Oka J, et al. (2011). The novel delta opioid receptor agonist KNT-127 produces antidepressant-like and antinociceptive effects in mice without producing convulsions. Behav Brain Res 223: 271-279.
205. Salvarezza SB, Deborde S, Schreiner R, Campagne F, Kessels MM, Qualmann B, et al. (2009). LIM kinase 1 and cofilin regulate actin filament population required for dynamin-dependent apical carrier fission from the trans-Golgi network. Mol Biol Cell 20: 438-451.
206. Scherrer G, Tryoen-Toth P, Filliol D, Matifas A, Laustriat D, Cao YQ, et al. (2006). Knockin mice expressing fluorescent delta-opioid receptors uncover G protein-coupled receptor dynamics in vivo. Proc Natl Acad Sci U S A 103: 9691-9696.
207. Scherrer G, Imamachi N, Cao YQ, Contet C, Mennicken F, O'Donnell D, et al. (2009). Dissociation of the opioid receptor mechanisms that control mechanical and heat pain. Cell 137: 1148-1159.
208. Schuster DJ, Kitto KF, Overland AC, Messing RO, Stone LS, Fairbanks CA, et al. (2013). Protein kinase C{epsilon} is required for spinal analgesic synergy between delta opioid and alpha-2A adrenergic receptor agonist pairs. J Neurosci 33: 13538-13546.
209. Shippenberg TS, Chefer VI, Thompson AC, (2009). Delta-opioid receptor antagonists prevent sensitization to the conditioned rewarding effects of morphine. Biol Psychiatry 65: 169-174.
210. Simmons D, Self DW, (2009). Role of mu- and delta-opioid receptors in the nucleus accumbens in cocaine-seeking behavior. Neuropsychopharmacology 34: 1946-1957.
211. Sluka KA, Rohlwing JJ, Bussey RA, Eikenberry SA, Wilken JM, (2002). Chronic muscle pain induced by repeated acid injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists. J Pharmacol Exp Ther 302: 1146-1150.
212. Sora I, Funada M, Uhl GR, (1997a). The mu-opioid receptor is necessary for [D-Pen2,D-Pen5]enkephalin-induced analgesia. Eur J Pharmacol 324: R1-R2.
213. Sora I, Takahashi N, Funada M, Ujike H, Revay RS, Donovan DM, et al. (1997b). Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc Natl Acad Sci U S A 94: 1544-1549.
214. Stewart PE, Hammond DL, (1994). Activation of spinal delta-1 or delta-2 opioid receptors reduces carrageenan-induced hyperalgesia in the rat. J Pharmacol Exp Ther 268: 701-708.
215. Stratinaki M, Varidaki A, Mitsi V, Ghose S, Magida J, Dias C, et al. (2013). Regulator of G protein signaling 4 [corrected] is a crucial modulator of antidepressant drug action in depression and neuropathic pain models. Proc Natl Acad Sci U S A 110: 8254-8259.
216. Sutters KA, Miaskowski C, Taiwo YO, Levine JD, (1990). Analgesic synergy and improved motor function produced by combinations of mu-delta- and mu-kappa-opioids. Brain Res 530: 290-294.
217. Tang B, Li Y, Yuan S, Tomlinson S, He S, (2013). Upregulation of the delta opioid receptor in liver cancer promotes liver cancer progression both in vitro and in vivo. Int J Oncol 43: 1281-1290.
218. Thorlin T, Eriksson PS, Hansson E, Ronnback L, (1997). [D-Pen2,5]enkephalin and glutamate regulate the expression of delta-opioid receptors in rat cortical astrocytes. Neurosci Lett 232: 67-70.
219. Thorlin T, Persson PA, Eriksson PS, Hansson E, Ronnback L, (1999). Delta-opioid receptor immunoreactivity on astrocytes is upregulated during mitosis. Glia 25: 370-378.
220. Tian X, Hua F, Sandhu HK, Chao D, Balboni G, Salvadori S, et al. (2013). Effect of delta-opioid receptor activation on BDNF-TrkB vs. TNF-alpha in the mouse cortex exposed to prolonged hypoxia. Int J Mol Sci 14: 15959-15976.
221. Tseng LF, Narita M, Mizoguchi H, Kawai K, Mizusuna A, Kamei J, et al. (1997). Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord. J Pharmacol Exp Ther 280: 600-605.
222. Tuusa JT, Leskela TT, Petaja-Repo UE, (2010). Human delta opioid receptor biogenesis is regulated via interactions with SERCA2b and calnexin. FEBS J 277: 2815-2829.
223. Ueda M, Sugimoto K, Oyama T, Kuraishi Y, Satoh M, (1995). Opioidergic inhibition of capsaicin-evoked release of glutamate from rat spinal dorsal horn slices. Neuropharmacology 34: 303-308.
224. Van Bockstaele EJ, Colago EE, Cheng P, Moriwaki A, Uhl GR, Pickel VM, (1996). Ultrastructural evidence for prominent distribution of the mu-opioid receptor at extrasynaptic sites on noradrenergic dendrites in the rat nucleus locus coeruleus. J Neurosci 16: 5037-5048.
225. Vogel Z, Barg J, Attali B, Simantov R, (1990). Differential effect of mu, delta, and kappa ligands on G protein alpha subunits in cultured brain cells. J Neurosci Res 27: 106-111.
226. Walwyn W, John S, Maga M, Evans CJ, Hales TG, (2009). Delta receptors are required for full inhibitory coupling of mu-receptors to voltage-dependent Ca(2+) channels in dorsal root ganglion neurons. Mol Pharmacol 76: 134-143.
227. Wang D, Sun X, Bohn LM, Sadee W, (2005). Opioid receptor homo- and heterodimerization in living cells by quantitative bioluminescence resonance energy transfer. Mol Pharmacol 67: 2173-2184.
228. Wang HB, Guan JS, Bao L, Zhang X, (2008a). Distinct subcellular distribution of delta-opioid receptor fused with various tags in PC12 cells. Neurochem Res 33: 2028-2034.
229. Wang HB, Zhao B, Zhong YQ, Li KC, Li ZY, Wang Q, et al. (2010). Coexpression of delta- and mu-opioid receptors in nociceptive sensory neurons. Proc Natl Acad Sci U S A 107: 13117-13122.
230. Wang Y, Van Bockstaele EJ, Liu-Chen LY, (2008b). In vivo trafficking of endogenous opioid receptors. Life Sci 83: 693-699.
231. Weibel R, Reiss D, Karchewski L, Gardon O, Matifas A, Filliol D, et al. (2013). Mu opioid receptors on primary afferent nav1.8 neurons contribute to opiate-induced analgesia: insight from conditional knockout mice. PLoS ONE 8: e74706.
232. Whistler JL, Tsao P, von Zastrow M, (2001). A phosphorylation-regulated brake mechanism controls the initial endocytosis of opioid receptors but is not required for post-endocytic sorting to lysosomes. J Biol Chem 276: 34331-34338.
233. Whistler JL, Enquist J, Marley A, Fong J, Gladher F, Tsuruda P, et al. (2002). Modulation of postendocytic sorting of G protein-coupled receptors. Science 297: 615-620.
234. Williams JT, Ingram SL, Henderson G, Chavkin C, von Zastrow M, Schulz S, et al. (2013). Regulation of mu-opioid receptors: desensitization, phosphorylation, internalization, and tolerance. Pharmacol Rev 65: 223-254.
235. Xiao K, Sun J, Kim J, Rajagopal S, Zhai B, Villen J, et al. (2010). Global phosphorylation analysis of beta-arrestin-mediated signaling downstream of a seven transmembrane receptor (7TMR). Proc Natl Acad Sci U S A 107: 15299-15304.
236. Xie CW, Lewis DV, (1995). Endogenous opioids regulate long-term potentiation of synaptic inhibition in the dentate gyrus of rat hippocampus. J Neurosci 15 (5 Pt 2): 3788-3795.
237. Xie WY, He Y, Yang YR, Li YF, Kang K, Xing BM, et al. (2009). Disruption of Cdk5-associated phosphorylation of residue threonine-161 of the delta-opioid receptor: impaired receptor function and attenuated morphine antinociceptive tolerance. J Neurosci 29: 3551-3564.
238. Yang Y, Zhi F, He X, Moore ML, Kang X, Chao D, et al. (2013). delta-opioid receptor activation and microRNA expression of the rat cortex in hypoxia. PLoS ONE 7: e51524.
239. Young E, Olney J, Akil H, (1982). Increase in delta, but not mu, receptors in MSG-treated rats. Life Sci 31: 1343-1346.
240. Young E, Olney J, Akil H, (1983). Selective alterations of opiate receptor subtypes in monosodium glutamate-treated rats. J Neurochem 40: 1558-1564.
241. Yu YJ, Dhavan R, Chevalier MW, Yudowski GA, von Zastrow M, (2010). Rapid delivery of internalized signaling receptors to the somatodendritic surface by sequence-specific local insertion. J Neurosci 30: 11703-11714.
242. Zachariou V, Goldstein BD, (1996). Delta-Opioid receptor modulation of the release of substance P-like immunoreactivity in the dorsal horn of the rat following mechanical or thermal noxious stimulation. Brain Res 736: 305-314.
243. Zhang X, Bao L, Arvidsson U, Elde R, Hokfelt T, (1998). Localization and regulation of the delta-opioid receptor in dorsal root ganglia and spinal cord of the rat and monkey: evidence for association with the membrane of large dense-core vesicles. Neuroscience 82: 1225-1242.
244. Zhang X, Wang F, Chen X, Li J, Xiang B, Zhang YQ, et al. (2005). Beta-arrestin1 and beta-arrestin2 are differentially required for phosphorylation-dependent and -independent internalization of delta-opioid receptors. J Neurochem 95: 169-178.
245. Zhang X, Bao L, Ma GQ, (2010). Sorting of neuropeptides and neuropeptide receptors into secretory pathways. Prog Neurobiol 90: 276-283.
246. Zhao B, Wang HB, Lu YJ, Hu JW, Bao L, Zhang X, (2011). Transport of receptors, receptor signaling complexes and ion channels via neuropeptide-secretory vesicles. Cell Res 21: 741-753.
247. Zhu Y, King MA, Schuller AG, Nitsche JF, Reidl M, Elde RP, et al. (1999). Retention of supraspinal delta-like analgesia and loss of morphine tolerance in delta opioid receptor knockout mice. Neuron 24: 243-252.
248. Zoudilova M, Kumar P, Ge L, Wang P, Bokoch GM, DeFea KA, (2007). Beta-arrestin-dependent regulation of the cofilin pathway downstream of protease-activated receptor-2. J Biol Chem 282: 20634-20646.
249. Zoudilova M, Min J, Richards HL, Carter D, Huang T, DeFea KA, (2010). beta-Arrestins scaffold cofilin with chronophin to direct localized actin filament severing and membrane protrusions downstream of protease-activated receptor-2. J Biol Chem 285: 14318-14329.